Refractory Depression: Current Strategies and Future Directions Book

	Contributors
	Preface
1	Epidemiology of Refractory Depression	3
2	Predictors of Non-response to Antidepressants	19
3	Treatment with Tricyclic Antidepressants: Defining the Refractory Patient	31
4	Selective Serotonin Reuptake Inhibitors in Refractory Depression	37
5	Lithium Addition in Refractory Depression	47
6	Classical and Selective Monoamine Oxidase Inhibitors in Refractory Major Depression	59
7	Refractory Depression and Electroconvulsive Therapy	69
8	The Roles of Psychosocial Factors and Psychotherapy in Refractory Depression: Missing Pieces in the Puzzle of Treatment Resistance?	83
9	Anticonvulsants in Refractory Mood Disorders	97
10	The Role of Cognitive Therapy in Refractory Depression	117
11	The Role of Thyroid Hormone in Refractory Depression	121
12	Sleep Deprivation in Refractory Depression	129
13	Potentiation of Fluoxetine by Buspirone and Trazodone in Refractory Depression	143
14	The Role of Psychostimulants in the Treatment of Depression	147
15	The Role of Oestrogen Augmentation in Females with Refractory Depression	155
16	The Role of Reserpine Augmentation in Refractory Depression	159
17	Changes in Low Frontal Cerebral Blood Flow Correlate with Outcome in Stereotactic Subcaudate Tractotomy Carried out for Refractory Depression	163
18	Alternative Approaches in Refractory Bipolar Depression	169
19	The Biological Basis of Refractory Depression	177
20	Assessment of Adrenocortical Activity in Refractory Depression: Steroid Suppression with Ketoconazole	199
21	Dopaminergic Drugs and Systems in Refractory Depression	211
	Index	229